LORATADINE
Generic: LORATADINE ORAL
Better Living Brands LLCManufacturer
ORALRoute
LORATADINEActive Substance
2018-06-29Original Approval
LORATADINE is FDA application ANDA208931, sponsored by AUROBINDO PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2014-02-07
Non-Drowsy 24 Hour Formula Allergy Relief and Nasal Decongestant, Pseudoephedrine Sulfate, USP 240 mg , Loratadine, USP,Defective Container: An unacceptable level of blister defects have been identified in Loratadine and
Class II2021-03-15
Children's Loratadine Oral Solution USP, 5 mg/5 mL (Antihistamine) Allergy Grape Flavor 4 FL OZ (120 mL) NDC 51672-2131-CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class III2021-10-12
Loratadine-D Extended-Release Tablets (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10mg/240mg)Failed Moisture Limits
Top Reported Reactions
1
DRUG INEFFECTIVE
3,928 reports
2
FATIGUE
3,417 reports
3
NAUSEA
2,863 reports
4
DYSPNOEA
2,572 reports
5
HEADACHE
2,559 reports
6
DIARRHOEA
2,501 reports
7
OFF LABEL USE
2,390 reports
8
DIZZINESS
2,226 reports
9
PAIN
2,071 reports
10
RASH
1,704 reports